Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
Open accessThe DOI matches its Crossref record; 375 of the 375 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock," published in 2004. DESIGN: Modified Delphi method with a consensus conference of 55 international experts, several subsequent meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee. This process was conducted independently of any industry funding. METHODS: We used the GRADE system to guide assessment of quality of evidence from high (A) to very low (D) and to determine the strength of recommendations. A strong recommendation indicates that an intervention's desirable effects clearly outweigh its undesirable effects (risk, burden, cost), or clearly do not. Weak recommendations indicate that the tradeoff between desirable and undesirable effects is less clear. The grade of strong or weak is considered of greater clinical importance than a difference in letter level of quality of evidence. In areas without complete agreement, a formal process of resolution was developed and applied. Recommendations are grouped into those directly targeting severe sepsis, recommendations targeting general care of the critically ill patient that are considered high priority in severe sepsis, and pediatric considerations. RESULTS: Key recommendations, listed by category, include: early goal-directed resuscitation of the septic patient during the first 6 hrs after recognition (1C); blood cultures prior to antibiotic therapy (1C); imaging studies performed promptly to confirm potential source of infection (1C); administration of broad-spectrum antibiotic therapy within 1 hr of diagnosis of septic shock (1B) and severe sepsis without septic shock (1D); reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate (1C); a usual 7-10 days of antibiotic therapy guided by clinical response (1D); source control with attention to the balance of risks and benefits of the chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid challenge to restore mean circulating filling pressure (1C); reduction in rate of fluid administration with rising filing pressures and no improvement in tissue perfusion (1D); vasopressor preference for norepinephrine or dopamine to maintain an initial target of mean arterial pressure > or = 65 mm Hg (1C); dobutamine inotropic therapy when cardiac output remains low despite fluid resuscitation and combined inotropic/vasopressor therapy (1C); stress-dose steroid therapy given only in septic shock after blood pressure is identified to be poorly responsive to fluid and vasopressor therapy (2C); recombinant activated protein C in patients with severe sepsis and clinical assessment of high risk for death (2B except 2C for post-operative patients). In the absence of tissue hypoperfusion, coronary artery disease, or acute hemorrhage, target a hemoglobin of 7-9 g/dL (1B); a low tidal volume (1B) and limitation of inspiratory plateau pressure strategy (1C) for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS); application of at least a minimal amount of positive end-expiratory pressure in acute lung injury (1C); head of bed elevation in mechanically ventilated patients unless contraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease days of mechanical ventilation and ICU length of stay, a conservative fluid strategy for patients with established ALI/ARDS who are not in shock (1C); protocols for weaning and sedation/analgesia (1B); using either intermittent bolus sedation or continuous infusion sedation with daily interruptions or lightening (1B); avoidance of neuromuscular blockers, if at all possible (1B); institution of glycemic control (1B) targeting a blood glucose < 150 mg/dL after initial stabilization ( 2C ); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophylaxis for deep vein thrombosis (1A); use of stress ulcer prophylaxis to prevent upper GI bleeding using H2 blockers (1A) or proton pump inhibitors (1B); and consideration of limitation of support where appropriate (1D). Recommendations specific to pediatric severe sepsis include: greater use of physical examination therapeutic end points (2C); dopamine as the first drug of choice for hypotension (2C); steroids only in children with suspected or proven adrenal insufficiency (2C); a recommendation against the use of recombinant activated protein C in children (1B). CONCLUSION: There was strong agreement among a large cohort of international experts regarding many level 1 recommendations for the best current care of patients with severe sepsis. Evidenced-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improved outcomes for this important group of
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Self-citation(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Self-citationGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Self-citationCenters for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Self-citationKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Self-citation
Cited by
Items 301–315 of 315
Drug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
Aaronson, E. L., Filbin, M. R., Brown, D. F. M., Tobin, K., & Mort, E. A. (2017) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.08.009 · Cited by 26
Cunha-Goncalves, D., Perez-de-Sa, V., Larsson, A., Thörne, J., & Blomquist, S. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181af40e0 · Cited by 24
Enteral nutrition in septic shock: A pathophysiologic conundrum
Patel, J. J., Shukla, A., & Heyland, D. K. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2246 · Cited by 24
Socioeconomic status and risk of intensive care unit admission with sepsis
Storm, L., Schnegelsberg, A., Mackenhauer, J., Andersen, L. W., Jessen, M. K., & Kirkegaard, H. (2018) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13114 · Cited by 24
Lindner, M., Padar, M., Mändul, M., Christopher, K. B., Reintam Blaser, A., Gratz, H., Elke, G., & Bachmann, K. F. (2023) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2502 · Cited by 22
Zhou, R., Sun, X., Li, Y., Huang, Q., Qu, Y., Mu, D., & Li, X. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.020 · Cited by 21
Bloise, F. F., van der Spek, A. H., Surovtseva, O. V., Ortiga-Carvalho, T. M., Fliers, E., & Boelen, A. (2016) · Thyroid · doi:10.1089/thy.2015.0536 · Cited by 21
Diagnosis of adrenal failure in critically ill patients
Moraes, R. B., Czepielewski, M. A., Friedman, G., & Borba, E. L. D. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000500001 · Cited by 20
Zwitterionic chitosan for the systemic treatment of sepsis
Cho, E. J., Doh, K.-O., Park, J., Hyun, H., Wilson, E. M., Snyder, P. W., Tsifansky, M. D., & Yeo, Y. (2016) · Scientific Reports · doi:10.1038/srep29739 · Cited by 18
Severe sepsis in do-not-resuscitate patients: intervention and mortality rates
Powell, E. S., Sauser, K., Cheema, N., Pirotte, M. J., Quattromani, E., Avula, U., Khare, R. K., & Courtney, D. M. (2013) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.09.034 · Cited by 17
Maternal sepsis in Italy: a prospective, population-based cohort and nested case-control study
Ornaghi, S., Maraschini, A., Buoncristiano, M., Corsi Decenti, E., Colciago, E., Cetin, I., Donati, S., & on behalf of the ItOSS-Regional Working Group (2022) · Microorganisms · doi:10.3390/microorganisms11010105 · Cited by 9
Barassi, A., Umbrello, M., Ghilardi, F., Damele, C. A. L., Massaccesi, L., Iapichino, G., & Melzi d’Eril, G. V. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.09.008 · Cited by 8
Guy, J. S., Jackson, E., & Perlin, J. B. (2020) · NEJM Catalyst · doi:10.1056/cat.19.1036 · Cited by 4
The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe
Majangara, R., Chirenje, Z. M., & Gidiri, M. F. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12695 · Cited by 4
Metadata
- Authors
- Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, J.-F., Gerlach, H., Harvey, M., Marini, J. J., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, B. T., Townsend, S., Vender, J. S., Zimmerman, J. L., & Vincent, J.-L.
- Venue
- Intensive Care Medicine
- Published
- 2007-12-04
- Volume
- 34
- Issue
- 1
- Pages
- 17-60
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2118858814
- Cited by
- 6,772
- References
- 375
- FWCI
- 311.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.